Summary
This 8-K filing by Walmart Inc. (WMT) on November 15, 2022, primarily serves to furnish a press release and financial presentation detailing their third-quarter results for the fiscal year ending January 31, 2023. Investors should note that this information is furnished, not filed, and will not be incorporated into future SEC filings unless expressly stated. The filing also discloses a significant development in Walmart's legal landscape regarding opioid-related lawsuits. Walmart has reached agreement on a nationwide settlement framework to resolve substantially all opioid-related lawsuits and potential claims from states, political subdivisions, and tribes. The total settlement amount is capped at approximately $3.1 billion, which includes some previously agreed-upon settlement amounts. Payment timelines are contingent on sufficient participation from states, political subdivisions, and tribes, with potential payments beginning as early as Q2 FY2024 for states and Q4 FY2023 for tribes. Importantly, the company makes no admission of wrongdoing or liability as part of these settlement frameworks.
Key Highlights
- 1Walmart is furnishing its Q3 FY2023 financial results via press release and presentation, not filing them in a way that impacts future SEC disclosures.
- 2The company has agreed to a nationwide settlement framework to resolve opioid-related litigation.
- 3The total potential settlement amount for opioid claims is up to approximately $3.1 billion.
- 4This settlement covers claims from states, political subdivisions, and tribes.
- 5Payment commencement is dependent on sufficient participation and could begin as early as Q4 FY2023 for tribal settlements and Q2 FY2024 for state settlements.
- 6The settlement frameworks include no admission of wrongdoing or liability by Walmart.
- 7Walmart will continue to defend against any litigation not covered by these settlement frameworks.